Abstract | INTRODUCTION: MATERIALS AND METHODS: 15 male rats were equally divided into three groups: group 1 was the sham-operated control group; group 2 had 2 h of unilateral testicular ischemia followed by 3 days of reperfusion, and group 3 had 2 h of unilateral testicular ischemia followed by 3 days of oral TMZ treatment (5 mg/kg, bid) during reperfusion. In the removed testicles, tissue reduced glutathione (GSH), glutathione reductase (GR), glutathione peroxidase (GPx), malondialdehyde (MDA) levels and pathological modified Johnson scores (MJS) were evaluated. Mann-Whitney U test was used for statistical evaluations. RESULTS: In group 2, on the ipsilateral side, GSH were significantly lower and MDA were higher than in groups 1 and 3, though GSH and MDA were not statistically different between groups 1 and 3. On the other hand, GPx in the control testicles of group 3 was significantly lower compared to those in the counterparts of both groups 1 and 2. Among three groups, GR determined in both testicles were not statistically different. On the ipsilateral side, MJS in group 3 were lower than in the sham group, but significantly higher than in group 2. CONCLUSIONS: According to this study, TMZ has an antioxidant effect on testicular torsion-detorsion injury, though the protective effect of TMZ seems to decrease in control testicles. Consequently it has been considered that TMZ can be only used in torsion patients with a healthy contralateral testicle after further studies have been conducted.
|
Authors | Dogan Unal, Omer F Karatas, Murat Savas, Ercan Yeni, Bulent S Keser, Ayhan Verit, Ozcan Erel, Muharrem Bitiren |
Journal | Urologia internationalis
(Urol Int)
Vol. 78
Issue 4
Pg. 356-62
( 2007)
ISSN: 0042-1138 [Print] Switzerland |
PMID | 17495496
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- Vasodilator Agents
- Trimetazidine
|
Topics |
- Animals
- Male
- Rats
- Rats, Sprague-Dawley
- Reperfusion Injury
(drug therapy)
- Testis
(drug effects, pathology)
- Treatment Outcome
- Trimetazidine
(pharmacology)
- Vasodilator Agents
(pharmacology)
|